Description
A potent autotaxin inhibitor (Ki = 15 nM); inhibits production of LPA in mouse, rat, and human plasma (IC50s = 418, 542, and 242 nM, respectively); reduces extracellular matrix deposition in the lung as well as LPA 18:2 levels in bronchoalveolar lavage fluid in a mouse model of bleomycin-induced pulmonary fibrosis at 30 mg/kg
Formal name: 2-[[2-ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-5-thiazolecarbonitrile
Synonyms:
Molecular weight: 588.7
CAS: 1628260-79-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Immunology & Inflammation|Pulmonary Diseases